60 Degrees Pharmaceuticals, Inc. has made a significant update regarding its ownership structure. In a recent filing, the company disclosed that Intracoastal Capital LLC and its affiliates have beneficial ownership of approximately 9.99% of its common stock. This development is noteworthy as it underscores the increasing interest in the pharmaceutical preparations industry.
The filing, dated November 10, 2026, reveals that the reporting persons, including Mitchell P. Kopin and Daniel B. Asher, collectively hold 390,342 shares of common stock. This ownership comprises shares issuable upon the exercise of various warrants held by Intracoastal Capital LLC. The filing indicates that as of September 30, 2026, the total shares outstanding were 3,516,988, based on previous reports by the issuer.
Background
60 Degrees Pharmaceuticals, Inc. operates within the pharmaceutical preparations sector, classified under SIC code 2834. The company is listed on the Nasdaq under the tickers SXTP and SXTPW. It is recognized as an emerging growth company, focusing on innovative solutions in the pharmaceutical industry.
What the Filing Says
The recent Schedule 13G/A filing indicates, "As of the close of business on September 30, 2026, each of the Reporting Persons may have been deemed to have beneficial ownership of 390,342 shares of Common Stock." This ownership is attributed to warrants held by Intracoastal Capital, which also includes specific provisions limiting the exercise of certain warrants to maintain compliance with ownership thresholds.
Impact
This update is likely to affect various stakeholders, including existing shareholders, potential investors, and market analysts. The significant shareholding by Intracoastal Capital LLC may influence the company's strategic decisions and market positioning. The filing does not specify any immediate changes in management or operational strategies as a result of this ownership update.
What's Next
The filing does not say what happens next. Stakeholders will be watching for any further developments or additional filings that may provide insight into the future direction of 60 Degrees Pharmaceuticals, Inc.
Read Next
Sven-Olof Lindblad sells shares in Lindblad Expeditions
Zeo Energy CEO Timothy Bridgewater Acquires 107,955 Shares
Manthripragada Vijay Acquires Additional Shares in Onterris
Laws James Acquires Shares in Onterris, Inc. via RSUs
Eightco Holdings CEO Acquires 100,000 Shares of Stock
Eightco CFO Vroman Acquires 15,000 Shares in Stock Transaction





